DUBLIN--(BUSINESS WIRE)--Oct 13, 2021--
The "North America Epithelial Cell Culture Media Market 2021-2028" report has been added to ResearchAndMarkets.com's offering.
The renal epithelial cell segment by product type is estimated to lead the market growth during the forecast period.
The North America epithelial cell culture media market is expected to reach US$ 1,16,662.91 thousand in 2028 from US$ 48,453.81 thousand in 2021; it is estimated to grow with a CAGR of 11.6% from 2021 to 2028.
The North America epithelial cell culture media market, by product type, is segmented human mammary epithelial cells, bronchia/trachea epithelial cells, renal epithelial cells, and others. The bronchia/trachea epithelial cells segment held the largest share of the market in 2020, whereas the renal epithelial cell segment is anticipated to register the highest CAGR in the market during the forecast period.
Epithelial cells are valuable in biology research to understand the function of living systems. For example, cervical epithelial cells provide an in vitro model for studying physiological processes associated with diseases such as cervical cancer, cervical polyps, and human papilloma virus (HPV) disease.
Further, epithelial cell lines are used in studies of drug transport processes. Drug transport studies in epithelial cells can be performed easily under controlled conditions, and they generate of important information. With the increasing applications of epithelial cells, the demand for media required to culture these cell lines is also on rise, which is boosting the epithelial cell culture media market growth. Extensive funding for supporting the research projects involving the use of epithelial cells to identify new therapeutic solutions for chronic diseases are propelling the demand for epithelial cell culture media.
For instance, the National Institutes of Health (NIH), US, funded a 3-year research project (2013-2016) that was conducted at the University of Kentucky. The institute granted US$ 307,395 in funds in 2014 to examine processes controlling inflammation in colitis, a condition that stimulates epithelial stem cell growth and differentiation and increases the risk of colon cancer. Hence, the increase in such grants for epithelial cell-based research projects are favouring the epithelial cells culture market growth.
North American region is highly affected due to the outbreak of the COVID-19 pandemic. The COVID-19 pandemic has negatively impacted all phases of drug development and forced many pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold.
Moreover, the ongoing COVID-19 crisis is likely to put additional pressure on the market to meet the future demand for cell and gene therapies. Further in North America, the COVID-19 pandemic has disrupted scientific research activities significantly as the pharmaceutical companies and research institution have shifted their research activities on vaccine for COVID-19. Thus, above mentioned factors are expected to hinder the growth of the market for a certain time.
The growth of the market is attributed to some key driving factors such as increasing applications of epithelial cells and rising funds for epithelial cells research across North America. However, risk of contamination, misidentification, and random alternations in cell lines is expected to obstruct the growth of the market to a certain extent during the forecast years.
Key Market Dynamics
- Increasing Applications of Epithelial Cells
- Surge in Funding for Epithelial Cell Research
- Risk of Contamination, Misidentification, and Random Alternations in Cell Lines
- Prospering Biopharmaceuticals Industries in Different Countries
- Adoption of Regenerative Medicines
- Thermo Fisher Scientific Inc.
- PromoCell GmbH
- MERCK KGaA
- Axol Bioscience Ltd.
- Celprogen, Inc
- HiMedia Laboratories
- Cell Biologics
- BIO-TECHNE CORPORATION
For more information about this report visit https://www.researchandmarkets.com/r/b4n0ww
View source version on businesswire.com:https://www.businesswire.com/news/home/20211013005779/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 10/13/2021 10:15 AM/DISC: 10/13/2021 10:17 AM